Red Book
Guidelines for the Blood Transfusion and Tissue Transplantation Services in the UK
The guidelines in the Red Book apply to the donation and preparation of materials derived from blood, tissue and stem cells by the UK Blood and Tissue Services for therapeutic and diagnostic use.
They reflect an expert view of current best practice, provide specifications for products and components, and describe technical details of processes.
View the guidelines
Search
Find guidance by searching
Chapters
See the full list of chapters
Updates
View all Red Book updates
Additional resources
About the Red Book
Learn more about these guidelines
Annexes
Annex 1
NIBSC standards available from MHRA
Annex 2
ISBT 128 check character calculation
Annex 3
Provisional component specifications
Annex 4
Redundant component specifications
Annex 5
Contingency component specifications
Annex 6
Advanced therapy medicinal products (ATMPs)
Annex 7
Requirements for timing of testing of haemopoetic progenitor cells
Latest updates
| Change number | Title | Updated | Guidelines affected |
|---|---|---|---|
| 02-2026 | Removal of vCJD risk from blood component labels (PDF only, 183KB) | 17 February 2026 | |
| 03-2026 | Red Book Chapter 23 (PDF only, 869KB) | 17 February 2026 | |
| 04-2026 | Red Book Chapter 3.4 (PDF only, 315KB) | 17 February 2026 | |
| 38-2025 | Red Cells for Neonates and Infants, Leucocyte Depleted, Washed (PDF only, 255KB) | 8 December 2025 | |
| 25-2025 | Red Cells and Plasma, Leucocyte Depleted (PDF only, 360KB) | 7 August 2025 |